BPC-157 works by encouraging new blood vessel formation (angiogenesis), boosting collagen production for healthier connective tissues, and reducing inflammation, thereby assisting in the healing of tendons, ligaments, and muscles
At hormonal levels, Copper Tripeptide-1 acts as a chemoattractant for fibroblasts (repairing cells) and activates a plethora of regenerative processes in the skin, such as angiogenesis, production of extracellular matrix components, including collagen, elastin, proteoglycans, glycosaminoglycans, etc, additionally activating metalloproteinases (MMPs) involved in tissue remodeling
In type 1 diabetes mellitus, which involves autoimmune -cell destruction, adjunctive therapy with GLP-1RA has shown promise in patients with residual -cell function
Other related GLP-1 agonists include Ozempic and Liraglutide, but these do not contain tirzepatide as their active ingredient, are not dual agonists, and use slightly different mechanisms
But it starts with an approach thats inclusive of all